Sunday, November 15, 2026

U.S. Fed Independence Under Threat as $1.1 Trillion Medicaid Cuts Risk Contagion to Global Markets

The One Big Beautiful Bill Act cuts $1.1 trillion from U.S. healthcare, leaving 11.8 million uninsured by 2034 as Fed Chair Jerome Powell's May 2026 departure threatens central bank independence. Markets price 40% odds of political interference in monetary policy by 2027, with Treasury term premiums widening 35 basis points: a risk pattern echoing Turkey's 2018 lira crisis when Erdogan pressured rate cuts.

ViaNews Editorial Team

February 26, 2026

From our archive, published before source-traceability. How we work

Source Trace Score10 source documents10 with a live linkVerifiability: Strong
U.S. Fed Independence Under Threat as $1.1 Trillion Medicaid Cuts Risk Contagion to Global Markets
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

The One Big Beautiful Bill Act strips $1.1 trillion from Medicaid and the Affordable Care Act, placing 11.8 million Americans at risk of losing coverage by 2034. The Congressional Budget Office warns the cuts accelerate Social Security and Medicare insolvency to 2032: eight years earlier than forecast.

Jerome Powell's Fed Chair term expires May 2026 amid succession fights that recall Turkey's 2018 central bank crisis, when President Erdogan's interference triggered currency collapse. Markets now price 40% probability of unconventional U.S. monetary policy interference by 2027. Treasury 10-year term premiums have widened 35 basis points since OBBBA passage began.

David Wessel at Brookings Institution calls Powell's potential exit "an existential moment for the Fed," warning presidential control over rate decisions would destroy credibility built since Paul Volcker's 1980s inflation fight. European Central Bank and Bank of England independence frameworks emerged from similar political pressures in the 1990s.

Only 24% of Social Security recipients gain tax relief under the new law, according to the Center for Budget and Policy Priorities. The narrow distribution contradicts administration claims while creating pressure for additional fiscal measures that threaten U.S. creditworthiness: a concern Japan faced during its 1990s lost decade.

Healthcare cuts hit financial markets through hospital bonds ($1.2 trillion outstanding) and medical real estate loans. Consumer bankruptcy filings typically surge 18-24 months after major coverage losses, a pattern seen in Greece during 2010-2015 austerity measures. Banks face repricing risk on government securities and municipal debt as fiscal credibility erodes.

A politically aligned Fed chair could delay Basel III capital rules and weaken post-2008 supervisory standards, undermining coordination with European and Asian regulators. The Federal Open Market Committee needs board independence to maintain market confidence: any compromise would reprice Treasury yields, mortgage rates, and corporate credit globally.

International investors hold $7.6 trillion in U.S. Treasuries. Political interference in Fed decisions would force foreign central banks to reassess dollar reserve allocations, potentially accelerating the shift toward euro and renminbi diversification that began during 2020 pandemic spending.

Source documents

Via News is a conduit. We point to the source documents behind this report: we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score10 source documents10 with a live linkVerifiability: Strong
  1. [1]News articleYahoo Finance· November 30, 2025
    Can you retire comfortably on Social Security alone? We asked seniors.
  2. [2]News articleYahoo Finance· December 10, 2025
    Fed has no 'tools' to solve affordability crisis: Torsten Sløk
  3. [3]News articleYahoo Finance· January 26, 2026
    How many rate cuts in 2026? These mounting pressures will put the Fed at a crossroads this year
  4. [4]News articleYahoo Finance· December 10, 2025
    How Much You Can Save on New Car Purchases in Every State Under Trump’s Tax Bill
  5. [5]News articleYahoo Finance· February 2, 2026
    Kevin Warsh’s Fed Will End the War on Main Street and Trucking
  6. [6]News articleYahoo Finance· January 20, 2026
    Taxes are going to change for retirees under Trump’s ‘big beautiful bill’. Here’s why you can’t afford to waste time
  7. [7]News articleYahoo Finance· January 23, 2026
    Trump says 88% of retirees will pay zero taxes on Social Security, calls it ‘the largest tax break in American history'
  8. [8]News articleYahoo Finance· November 8, 2025
    Trump says 88% of US retirees will now pay zero taxes on Social Security, but can the One Big Beautiful Bill hurt you?
  9. [9]News articleYahoo Finance· February 21, 2026
    Germany About to Find Out Whether Its Recovery Is Real
  10. [10]News articleYahoo Finance· November 26, 2025
    UK budget: financial services sector reaction

Are you or your business in this article?

If something is wrong, out of context or missing, tell us. We correct errors with a dated note, and people named in an article can publish their response under it.

Correct, add context or respond →

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source, and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,580 source documents archived
Query this data → isubstrate.com